том 21 издание 5 страницы 910-917

Antiplatelet and Anticoagulant Risk for Select Spine Interventions: A Retrospective Cohort

Тип публикацииJournal Article
Дата публикации2020-02-17
scimago Q1
wos Q1
white level БС1
SJR0.982
CiteScore6.7
Impact factor3
ISSN15262375, 15264637
General Medicine
Anesthesiology and Pain Medicine
Neurology (clinical)
Краткое описание
Objectives

To identify significant bleeding complications following spinal interventions in patients taking medications with antiplatelet or anticoagulation effect.

Design

Retrospective chart review of a 12-month period.

Setting

Outpatient academic medical practice.

Interventions

Injections during outpatient interventional spine clinical encounters, including 14 cervical transforaminal epidural steroid injections, 26 cervical medial branch blocks, seven cervical radiofrequency neurotomies, three cervical facet joint injections, 88 lumbar transforaminal epidural steroid injections, 66 lumbosacral medial branch blocks, 18 lumbosacral radiofrequency neurotomies, 13 lumbar facet joint injections, one caudal epidural steroid injection, 11 sacral transforaminal epidural steroid injections, and 32 sacroiliac joint injections.

Main Outcome Measure

Epidural hematoma or other serious bleeding.

Results

In this cohort of 275 consecutive encounters with available records in which patients underwent a spinal injection while continuing medications with antiplatelet or anticoagulant effect, zero of the 275 clinical encounters (0%, 95% confidence interval = 0–1.4%) resulted in epidural hematoma or other serious bleeding. For antiplatelet medication, nonsteroidal anti-inflammatory drugs were continued in 102 procedures, aspirin in 142, clopidogrel in 21, and meloxicam and/or Celebrex in 81; for anticoagulation medication, warfarin was continued in four procedures, apixaban in six, dabigatran in one, and fondaparinux in two. Of note, one patient suffered a deep vein thrombosis, which was identified at two-week follow-up despite continuing aspirin therapy.

Conclusions

This cohort adds to the growing evidence that the risk of serious bleeding complications from select spine interventions while continuing medications with antiplatelet or anticoagulant effect appears low.

Для доступа к списку цитирований публикации необходимо авторизоваться.

Топ-30

Журналы

1
2
3
4
Pain Medicine
4 публикации, 25%
Interventional Pain Medicine
3 публикации, 18.75%
Musculoskeletal Care
1 публикация, 6.25%
Reactions Weekly
1 публикация, 6.25%
Rheumatology International
1 публикация, 6.25%
Physical Medicine and Rehabilitation Clinics of North America
1 публикация, 6.25%
Regional Anesthesia and Pain Medicine
1 публикация, 6.25%
Global Spine Journal
1 публикация, 6.25%
Current Pain and Headache Reports
1 публикация, 6.25%
Journal of Clinical Neuroscience
1 публикация, 6.25%
1
2
3
4

Издатели

1
2
3
4
5
6
Elsevier
6 публикаций, 37.5%
Oxford University Press
4 публикации, 25%
Springer Nature
3 публикации, 18.75%
Wiley
1 публикация, 6.25%
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 6.25%
SAGE
1 публикация, 6.25%
1
2
3
4
5
6
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
16
Поделиться
Цитировать
ГОСТ |
Цитировать
Rosati R. M. et al. Antiplatelet and Anticoagulant Risk for Select Spine Interventions: A Retrospective Cohort // Pain Medicine. 2020. Vol. 21. No. 5. pp. 910-917.
ГОСТ со всеми авторами (до 50) Скопировать
Rosati R. M., Ehsanian R., Kennedy D. J., Schneider B. J. Antiplatelet and Anticoagulant Risk for Select Spine Interventions: A Retrospective Cohort // Pain Medicine. 2020. Vol. 21. No. 5. pp. 910-917.
RIS |
Цитировать
TY - JOUR
DO - 10.1093/pm/pnaa009
UR - https://doi.org/10.1093/pm/pnaa009
TI - Antiplatelet and Anticoagulant Risk for Select Spine Interventions: A Retrospective Cohort
T2 - Pain Medicine
AU - Rosati, Renee M
AU - Ehsanian, Reza
AU - Kennedy, David J.
AU - Schneider, Byron J.
PY - 2020
DA - 2020/02/17
PB - Oxford University Press
SP - 910-917
IS - 5
VL - 21
PMID - 32361741
SN - 1526-2375
SN - 1526-4637
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2020_Rosati,
author = {Renee M Rosati and Reza Ehsanian and David J. Kennedy and Byron J. Schneider},
title = {Antiplatelet and Anticoagulant Risk for Select Spine Interventions: A Retrospective Cohort},
journal = {Pain Medicine},
year = {2020},
volume = {21},
publisher = {Oxford University Press},
month = {feb},
url = {https://doi.org/10.1093/pm/pnaa009},
number = {5},
pages = {910--917},
doi = {10.1093/pm/pnaa009}
}
MLA
Цитировать
Rosati, Renee M., et al. “Antiplatelet and Anticoagulant Risk for Select Spine Interventions: A Retrospective Cohort.” Pain Medicine, vol. 21, no. 5, Feb. 2020, pp. 910-917. https://doi.org/10.1093/pm/pnaa009.
Ошибка в публикации?